DK382889D0 - Konjugater af antistoffer og cytotoxiske methotrexat-forbindelser og fremgangsmaade til fremstilling af saadanne konjugater - Google Patents
Konjugater af antistoffer og cytotoxiske methotrexat-forbindelser og fremgangsmaade til fremstilling af saadanne konjugaterInfo
- Publication number
- DK382889D0 DK382889D0 DK382889A DK382889A DK382889D0 DK 382889 D0 DK382889 D0 DK 382889D0 DK 382889 A DK382889 A DK 382889A DK 382889 A DK382889 A DK 382889A DK 382889 D0 DK382889 D0 DK 382889D0
- Authority
- DK
- Denmark
- Prior art keywords
- conjugates
- methotrexate
- cytotoxic
- antibodies
- procedures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/229,941 US5028697A (en) | 1988-08-08 | 1988-08-08 | Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers |
Publications (2)
Publication Number | Publication Date |
---|---|
DK382889D0 true DK382889D0 (da) | 1989-08-04 |
DK382889A DK382889A (da) | 1990-02-09 |
Family
ID=22863313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK382889A DK382889A (da) | 1988-08-08 | 1989-08-04 | Konjugater af antistoffer og cytotoxiske methotrexat-forbindelser og fremgangsmaade til fremstilling af saadanne konjugater |
Country Status (14)
Country | Link |
---|---|
US (1) | US5028697A (da) |
EP (1) | EP0354729B1 (da) |
JP (1) | JPH02256700A (da) |
KR (1) | KR900002803A (da) |
CN (1) | CN1040204A (da) |
AU (1) | AU619328B2 (da) |
DE (1) | DE68912232T2 (da) |
DK (1) | DK382889A (da) |
HU (1) | HU208161B (da) |
IL (1) | IL91181A0 (da) |
MX (1) | MX165003B (da) |
NZ (1) | NZ230199A (da) |
PT (1) | PT91371B (da) |
ZA (1) | ZA895909B (da) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5010176A (en) * | 1988-11-10 | 1991-04-23 | Eli Lilly And Company | Antibody-drug conjugates |
US5977307A (en) * | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
US5672683A (en) * | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
US6329508B1 (en) | 1989-09-07 | 2001-12-11 | Alkermes, Inc. | Transferrin receptor reactive chimeric antibodies |
ZA914625B (en) * | 1990-06-22 | 1993-02-24 | Lilly Co Eli | In vivo targeting with bifunctional antibodies |
US5272253A (en) * | 1991-07-01 | 1993-12-21 | Eli Lilly And Company | Cluster conjugates of drugs with antibodies |
GR1001459B (el) * | 1992-10-08 | 1993-12-30 | Lilly Co Eli | Σύμπλεγμα συζυγών φαρμάκων με αντισώματα. |
US5382582A (en) * | 1993-03-26 | 1995-01-17 | Chan; Carcy L. | Methotrexate analogs and methods of using same |
US5556623A (en) * | 1993-03-30 | 1996-09-17 | Eli Lilly And Company | Antibody-drug conjugates |
JPH072895A (ja) * | 1993-04-28 | 1995-01-06 | Eli Lilly & Co | 抗体−薬物複合体 |
US5773001A (en) * | 1994-06-03 | 1998-06-30 | American Cyanamid Company | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
US6015555A (en) * | 1995-05-19 | 2000-01-18 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
US5712374A (en) * | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
US5698556A (en) * | 1995-06-07 | 1997-12-16 | Chan; Carcy L. | Methotrexate analogs and methods of using same |
US5714586A (en) * | 1995-06-07 | 1998-02-03 | American Cyanamid Company | Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
US20030119724A1 (en) * | 1995-11-22 | 2003-06-26 | Ts`O Paul O.P. | Ligands to enhance cellular uptake of biomolecules |
US6906182B2 (en) | 2000-12-01 | 2005-06-14 | Cell Works Therapeutics, Inc. | Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and method of use |
US20100056762A1 (en) | 2001-05-11 | 2010-03-04 | Old Lloyd J | Specific binding proteins and uses thereof |
JP4414142B2 (ja) | 2001-05-11 | 2010-02-10 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | 特異的結合タンパク質およびその使用 |
BRPI0406647A (pt) * | 2003-01-06 | 2005-12-06 | Angiochem Inc | Método para transportar um composto através da barreira sanguìnea do cérebro |
WO2006031614A2 (en) * | 2004-09-10 | 2006-03-23 | Tosk, Inc. | Reduced toxicity methotrexate formulations and methods for using the same |
ES2527634T3 (es) * | 2005-02-18 | 2015-01-27 | Angiochem Inc. | Polipéptidos de aprotinina para transportar un compuesto a través de la barrera sangre-cerebro |
US20090016959A1 (en) * | 2005-02-18 | 2009-01-15 | Richard Beliveau | Delivery of antibodies to the central nervous system |
SI2233156T1 (sl) | 2005-07-15 | 2013-09-30 | Angiochem Inc. | Uporaba polipeptidov aprotinina kot nosilce v farmacevtskih konjugatih |
CA2631014C (en) | 2005-11-28 | 2015-04-28 | Vernon D. Rowe | Compositions useful for reducing nephrotoxicity and methods of use thereof |
CN101711284A (zh) | 2007-01-25 | 2010-05-19 | 达娜-法勃肿瘤研究所 | 抗egfr抗体在治疗egfr突变体介导的疾病中的用途 |
MX2009009782A (es) | 2007-03-15 | 2010-09-10 | Ludwig Inst Cancer Res | Metodo de tratamiento que utiliza anticuerpos egfr e inhibidores de src y formulaciones relacionadas. |
US9365634B2 (en) * | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
CA2696360C (en) | 2007-08-14 | 2018-11-20 | Ludwig Institute For Cancer Research | Monoclonal antibody targeting the egfr receptor and uses thereof |
EP2265274B1 (en) | 2008-03-03 | 2018-11-21 | Tosk, Inc. | Methotrexate adjuvants to reduce toxicity and methods for using the same |
JP5860698B2 (ja) * | 2008-04-18 | 2016-02-16 | アンジオケム,インコーポレーテッド | パクリタキセル、パクリタキセル類似体またはパクリタキセルコンジュゲートの医薬組成物ならびに関連する調製方法および使用方法 |
RU2531591C2 (ru) | 2008-10-15 | 2014-10-20 | Ангиокем Инк. | Конъюгаты этопозида и доксорубицина для доставки лекарственных средств |
US8921314B2 (en) | 2008-10-15 | 2014-12-30 | Angiochem, Inc. | Conjugates of GLP-1 agonists and uses thereof |
CN102307904A (zh) * | 2008-12-05 | 2012-01-04 | 安吉奥开米公司 | 神经降压素或神经降压素类似物的缀合物及其用途 |
JP2012512185A (ja) | 2008-12-17 | 2012-05-31 | アンジオケム インコーポレーテッド | 膜1型マトリックス金属タンパク質阻害剤およびその使用 |
CA2759129C (en) | 2009-04-20 | 2018-12-11 | Angiochem Inc. | Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog |
AU2010268726A1 (en) | 2009-07-02 | 2012-01-19 | Angiochem Inc. | Multimeric peptide conjugates and uses thereof |
EP3824890A1 (en) | 2011-05-16 | 2021-05-26 | Genzyme Corporation | Induction of immune tolerance using methotrexate |
WO2014144871A1 (en) | 2013-03-15 | 2014-09-18 | The Centre For Drug Research And Development | Cytotoxic and anti-mitotic compounds, and methods of using the same |
JP6560681B2 (ja) | 2013-12-27 | 2019-08-14 | ザイムワークス インコーポレイティド | 薬物結合体のためのスルホンアミド含有連結系 |
IL287645B2 (en) | 2014-09-17 | 2024-04-01 | Zymeworks Bc Inc | Cytotoxic and anti-mitotic compounds and methods for their use |
WO2016205367A1 (en) | 2015-06-15 | 2016-12-22 | Angiochem Inc. | Methods for the treatment of leptomeningeal carcinomatosis |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI820020L (fi) * | 1981-01-12 | 1982-07-13 | Lilly Industries Ltd | Immunoglobulinkonjugater |
US4631190A (en) * | 1981-06-26 | 1986-12-23 | Shen Wei C | Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers |
AU8762982A (en) * | 1981-07-02 | 1983-02-02 | Walton, A.G. | Glycosaminoglycan drug complexes |
US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
CA1203164A (en) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Antibody conjugates |
ATE53496T1 (de) * | 1983-03-30 | 1990-06-15 | Lilly Industries Ltd | Immunoglobulinkonjugate. |
US4699784A (en) * | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
GB8610551D0 (en) * | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
CA1330378C (en) * | 1986-05-08 | 1994-06-21 | Daniel J. Coughlin | Amine derivatives of folic acid analogs |
US4997913A (en) * | 1986-06-30 | 1991-03-05 | Oncogen | pH-sensitive immunoconjugates and methods for their use in tumor therapy |
EP0279862B1 (en) * | 1986-08-28 | 1993-11-03 | Teijin Limited | Cytocidal antibody complex and process for its preparation |
IE63869B1 (en) * | 1986-11-06 | 1995-06-14 | Res Dev Foundation | Aerosols containing liposomes and method for their preparation |
US4918165A (en) * | 1987-07-16 | 1990-04-17 | Ophthalmic Research Corporation | Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
-
1988
- 1988-08-08 US US07/229,941 patent/US5028697A/en not_active Expired - Fee Related
-
1989
- 1989-08-02 ZA ZA895909A patent/ZA895909B/xx unknown
- 1989-08-02 IL IL91181A patent/IL91181A0/xx unknown
- 1989-08-03 EP EP89307916A patent/EP0354729B1/en not_active Expired - Lifetime
- 1989-08-03 PT PT91371A patent/PT91371B/pt not_active IP Right Cessation
- 1989-08-03 DE DE68912232T patent/DE68912232T2/de not_active Expired - Fee Related
- 1989-08-03 NZ NZ230199A patent/NZ230199A/xx unknown
- 1989-08-04 DK DK382889A patent/DK382889A/da not_active Application Discontinuation
- 1989-08-04 AU AU39338/89A patent/AU619328B2/en not_active Ceased
- 1989-08-04 MX MX17078A patent/MX165003B/es unknown
- 1989-08-07 KR KR1019890011216A patent/KR900002803A/ko not_active Application Discontinuation
- 1989-08-07 JP JP1205544A patent/JPH02256700A/ja active Pending
- 1989-08-07 CN CN89106471A patent/CN1040204A/zh active Pending
- 1989-08-07 HU HU893993A patent/HU208161B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA895909B (en) | 1991-04-24 |
EP0354729A3 (en) | 1991-04-17 |
US5028697A (en) | 1991-07-02 |
HU208161B (en) | 1993-08-30 |
CN1040204A (zh) | 1990-03-07 |
NZ230199A (en) | 1991-09-25 |
MX165003B (es) | 1992-10-13 |
AU3933889A (en) | 1990-02-08 |
AU619328B2 (en) | 1992-01-23 |
DE68912232T2 (de) | 1994-05-19 |
DE68912232D1 (de) | 1994-02-24 |
IL91181A0 (en) | 1990-03-19 |
JPH02256700A (ja) | 1990-10-17 |
PT91371B (pt) | 1995-05-04 |
HUT50850A (en) | 1990-03-28 |
DK382889A (da) | 1990-02-09 |
KR900002803A (ko) | 1990-03-23 |
EP0354729A2 (en) | 1990-02-14 |
EP0354729B1 (en) | 1994-01-12 |
PT91371A (pt) | 1990-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK382889D0 (da) | Konjugater af antistoffer og cytotoxiske methotrexat-forbindelser og fremgangsmaade til fremstilling af saadanne konjugater | |
DK612789A (da) | Fremgangsmaade til fremstilling af pyridinderivater | |
DK640989D0 (da) | Mikrobiologisk fremgangsmaade til fremstilling af immunundertrykkende antibiotika | |
DK556689A (da) | Antistof-konjugater, fremgangsmaade til fremstilling heraf og farmaceutiske midler indeholdende disse | |
DK581688A (da) | L-tyrosinderivater og fremgangsmaade til fremstilling af samme | |
DK4189A (da) | Oxadiazolforbindelse, farmaceutisk praeparat indeholdende og fremgangsmaade til fremstilling af forbindelsen | |
DK250689A (da) | Fremgangsmaade til fremstilling af napthalenderivater | |
DK665489A (da) | Fremgangsmaade til fremstilling af mono-n-alkylerede polyazamakrocykliske forbindelser | |
DK102990D0 (da) | Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
DK30489A (da) | Fremgangsmaade til fremstilling af pyranderivater | |
PT86960A (pt) | Process for the preparation of immunoglobulin conjugates | |
DK635988D0 (da) | 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater | |
DK115291A (da) | Fremgangsmaade til fremstilling af amfotere overfladeaktive imidazolinderivater | |
DK601489A (da) | Fremgangsmaade til fremstilling af alkansulfonamider | |
DK0458855T3 (da) | Farmaceutisk præparat til behandling af tonsillitis | |
DK314988A (da) | Fremgangsmaade til fremstilling af 6-deoxyguaninderivater | |
DK291189D0 (da) | Kondenserede diazepinoner, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler med indhold af forbindelserne | |
DK28788D0 (da) | Fremgangsmaade til fremstilling af alkansulfonamider | |
DK455889A (da) | Fremgangsmaade til fremstilling af kulhydratderivater | |
DK231990D0 (da) | Fremgangsmaade til fremstilling af emballagevaeg | |
DK113189D0 (da) | Fremgangsmaade til fremstilling af pyridinderivater | |
DK143889A (da) | Fremgangsmaade til fremstilling af naphthalenderivater | |
DK97388D0 (da) | Mellemprodukt og fremgangsmaade til fremstilling af antihypercholestrolemiske tetrazolforbindelser | |
DK293589D0 (da) | Fremgangsmaade til fremstiling af lactolderivater | |
DK100392D0 (da) | 3- og 5-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt forbindelsernes anvendelse til fremstilling af laegemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |